David Truong ,

  • Assistant Professor of Biomedical Engineering and Pathology



Dr. Truong works in the area of synthetic and systems biology, where he and his lab focus on building synthetic genomes and engineered cell therapies. They perform large scale human genome engineering in pluripotent stem cells (iPSCs), because these cells may become any cell in the body. The lab turns these engineered cells into "off-the-shelf" somatic cells with therapeutic potential, focusing initially on immune cell types. The potential applications of these engineered cells include cancer cell immunotherapy, cell replacement therapy, tissue regeneration, and reducing autoimmune dysfunction.

Research Interests: Synthetic Biology, Cell therapies, Immunotherapy, Regenerative medicine, Genome engineering, Cancer, Genomics, Aging, Neurodegeneration, Stem cell biology, Epigenetics, Biomanufacturing

  • B.S. - University of California San Diego
  • Ph.D. - The University of Texas at Austin
  • Postdoctoral Fellowship - NYU Langone Health

  • NIH (NIAID) Director's New Innovator Award (DP2)
  • NIAID Small Business Innovative Research Award (SBIR)
  • Delil Nasser Award for Professional Development, Genetics Society of America
  • NIH (NIGMS) Ruth L. Kirschstein National Research Service Award
  • National Science Foundation Graduate Research Fellowship (honorable mention)


Associated Faculty - NYU Grossman School of Medicine - Department of Pathology

Member, Translational Immunology Center

Member, Perlmutter Cancer Center

Founding Team - Neochromosome Inc, a synthetic genomics company

US11053289B2 - 2021 - Budding yeast with human chromatin

Research Briefs

Sep 1, 2021